India’s Growth Ambitions, AI Investment and Global Economic Risks

From the Bloomberg New Economy Forum in New Delhi, Haslinda Amin examines India’s economic outlook amid geopolitical tensions, shifting trade patterns and rapid AI investment. Interviews with the IMF’s chief economist, Atlassian CEO Mike Cannon-Brookes and Piramal Pharma chairperson Nandini Piramal offer perspectives on global growth, enterprise AI and pharmaceutical supply chains.

- India’s economy: growth, inflation, the rupee and the country’s role in attracting investment
- IMF outlook: global growth, AI-driven investment, productivity questions and risks to resilience
- Enterprise AI: Atlassian’s approach to AI adoption, competing models, costs and data compliance
- Uncertainty and industry: a forum discussion on geopolitical and technological risks, plus Piramal Pharma’s costs, sourcing and U.S. expansion

For investors, business leaders and viewers following India, AI or global trade, these conversations provide context on the issues shaping current business decisions. Consider comparing the risks discussed with the indicators relevant to your industry; the coverage does not provide a detailed policy or investment plan.